Literature DB >> 2337493

Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin.

J M Rawles1, M J Metcalfe, K Jennings.   

Abstract

One hundred and thirty nine episodes of atrial fibrillation were identified from Holter recordings in 72 patients with paroxysmal atrial fibrillation. Paroxysms occurred more often by day than by night, suggesting that attacks are more closely associated with sympathetic than with vagal activity. In 41 patients who were not taking digoxin there were 79 episodes, and in 31 patients who were taking digoxin there were 60 episodes. Significantly more of the episodes that lasted for 30 minutes or more occurred in patients taking digoxin (13/17); the relative risk of a prolonged paroxysm associated with taking digoxin was 4.3 (95% confidence intervals 1.6-11.9). The mean (SD) ventricular rate at the onset of the paroxysms was not significantly different in those taking digoxin (140 (25) beats/min) and in those who were not (134 (22) beats/min). In paroxysmal atrial fibrillation, pretreatment with digoxin does not seem to reduce the frequency of paroxysms, or the ventricular rate when paroxysms occur, but it is associated with longer attacks.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2337493      PMCID: PMC1024435          DOI: 10.1136/hrt.63.4.225

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  7 in total

1.  MODE OF ONSET OF ATRIAL FIBRILLATION IN MAN.

Authors:  T KILLIP; J H GAULT
Journal:  Am Heart J       Date:  1965-08       Impact factor: 4.749

2.  Nonuniform distribution of vagal effects on the atrial refractory period.

Authors:  R ALESSI; M NUSYNOWITZ; J A ABILDSKOV; G K MOE
Journal:  Am J Physiol       Date:  1958-08

3.  Propafenone for paroxysmal atrial fibrillation.

Authors:  S C Hammill; D L Wood; B J Gersh; M J Osborn; D R Holmes
Journal:  Am J Cardiol       Date:  1988-02-15       Impact factor: 2.778

4.  [The atrial arrhythmia syndrome of vagal origin].

Authors:  P Coumel; P Attuel; J Lavallée; D Flammang; J F Leclercq; R Slama
Journal:  Arch Mal Coeur Vaiss       Date:  1978-06

Review 5.  A nomogram for digoxin therapy.

Authors:  R W Jelliffe; G Brooker
Journal:  Am J Med       Date:  1974-07       Impact factor: 4.965

6.  Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation.

Authors:  R Beasley; D A Smith; D J McHaffie
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-05

7.  New method for assessing cardiac parasympathetic activity using 24 hour electrocardiograms.

Authors:  D J Ewing; J M Neilson; P Travis
Journal:  Br Heart J       Date:  1984-10
  7 in total
  25 in total

Review 1.  Which patient should be referred to an electrophysiologist: supraventricular tachycardia.

Authors:  Richard J Schilling
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

Review 2.  Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment.

Authors:  Vias Markides; Richard J Schilling
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

3.  Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin.

Authors:  R H Falk
Journal:  Br Heart J       Date:  1990-12

Review 4.  When, and when not, to use digoxin in the elderly.

Authors:  A T Gosselink; D J van Veldhuisen; H J Crijns
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

5.  Withdrawal of maintenance digoxin from institutionalized elderly.

Authors:  B J Liddle
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

Review 6.  Does digoxin still have a role in congestive heart failure?

Authors:  S S Kothari
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

Review 7.  Atrial fibrillation: how to approach rate control.

Authors:  Lynda E Rosenfeld
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

Review 8.  Emergency management of atrial fibrillation.

Authors:  A Wakai; J O O'Neill
Journal:  Postgrad Med J       Date:  2003-06       Impact factor: 2.401

Review 9.  Pharmacologic management of atrial fibrillation in the elderly: rate control, rhythm control, and anticoagulation.

Authors:  Seth McClennen; Peter J Zimetbaum
Journal:  Curr Cardiol Rep       Date:  2003-09       Impact factor: 2.931

10.  Circadian distribution of paroxysmal atrial fibrillation in patients with and without structural heart disease in untreated state.

Authors:  Yoshiaki Deguchi; Mari Amino; Kumiko Adachi; Atsushi Matsuzaki; Osamu Iwata; Koichiro Yoshioka; Eiichi Watanabe; Teruhisa Tanabe
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-07       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.